English
norskMottak til pasientens beste : erfaringer fra et lokalsykehus i endring
| dc.contributor.author | Sørlie, Venke | |
| dc.contributor.author | Guttormsen, Torbjørg | |
| dc.contributor.author | Finstad, Helga Helland | |
| dc.date.accessioned | 2011-04-08T09:10:30Z | |
| dc.date.available | 2011-04-08T09:10:30Z | |
| dc.date.issued | 2010 | |
| dc.identifier.citation | Nordisk tidsskrift for helseforskning 6(2010) nr. 2 s. 3-13 | en |
| dc.identifier.cristinID | FRIDAID 516404 | |
| dc.identifier.issn | 1504-3614 | |
| dc.identifier.uri | https://hdl.handle.net/10037/3116 | |
| dc.identifier.urn | URN:NBN:no-uit_munin_2847 | |
| dc.language.iso | nob | en |
| dc.publisher | Høgskolen i Bodø | en |
| dc.rights.accessRights | openAccess | |
| dc.subject | VDP::Medical disciplines: 700::Health sciences: 800::Health service and health administration research: 806 | en |
| dc.subject | VDP::Medisinske Fag: 700::Helsefag: 800::Helsetjeneste- og helseadministrasjonsforskning: 806 | en |
| dc.subject | VDP::Medical disciplines: 700::Health sciences: 800::Other health science disciplines: 829 | en |
| dc.subject | VDP::Medisinske Fag: 700::Helsefag: 800::Andre helsefag: 829 | en |
| dc.title | Mottak til pasientens beste : erfaringer fra et lokalsykehus i endring | en |
| dc.type | Journal article | en |
| dc.type | Tidsskriftartikkel | en |
| dc.type | Peer reviewed | en |
File(s) in this item
This item appears in the following collection(s)
Related items
Showing items related by title, author, creator and subject.
-
Cochrane Collaboration Systematic Reviews may be based on trials not approved by a research ethics committee
(Journal article; Tidsskriftartikkel; Peer reviewed, 2017-10-27)Systematic reviews (SR) may potentially contain reports of primary trials with ethical problems. The Cochrane Collaboration SRs are considered as the highest standard in evidence-based health care resources. All SRs completed during the last 5 years (2013–2017) under the management of the Oral Health Group of the Cochrane Collaboration were identified. All primary trials included in the Oral Health ... -
Pembrolizumab as second-line therapy in non-small cell lung cancer in northern Norway: budget impact and expected gain—a model-based analysis
(Journal article; Tidsskriftartikkel; Peer reviewed, 2017-07-29)1 Norum J, et al . ESMO Open 2017; 2 :e000222. doi:10.1136/esmoopen-2017-000222 Open Access Abstr A ct Background P embrolizumab is a new drug approved in several countries for second-line therapy in non-small cell lung cancer (NSCLC) being programmed cell death ligand (PD-L1) positive. This drug has a high cost, and the cost- effectiveness ratio has been debated. Patients ... -
The Use of eHealth and Provider-Based Health Services by Patients with Diabetes Mellitus: Protocol for a Cross-Sectional Study
(Journal article; Tidsskriftartikkel; Peer reviewed, 2016-10-31)<b>Background:</b> The prevalence of diabetes and the use of electronic health (eHealth) resources are increasing. People with diabetes need frequent monitoring and follow-up of health parameters, and eHealth services can be of great significance in this regard. However, little is known about the extent to which different kinds of eHealth tools are used, and how the use of eHealth is associated ...
